US6020177A - Heptaprenyl diphosphate-synthetase - Google Patents

Heptaprenyl diphosphate-synthetase Download PDF

Info

Publication number
US6020177A
US6020177A US09/035,754 US3575498A US6020177A US 6020177 A US6020177 A US 6020177A US 3575498 A US3575498 A US 3575498A US 6020177 A US6020177 A US 6020177A
Authority
US
United States
Prior art keywords
leu
amino acid
seq
ala
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US09/035,754
Inventor
Ayumi Koike
Shusei Obata
Kyozo Ogura
Tanetoshi Koyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyota Motor Corp
Original Assignee
Toyota Motor Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyota Motor Corp filed Critical Toyota Motor Corp
Priority to US09/035,754 priority Critical patent/US6020177A/en
Application granted granted Critical
Publication of US6020177A publication Critical patent/US6020177A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/832—Bacillus

Definitions

  • the present invention relates to heptaprenyl diphosphate (hereunder sometimes abbreviated to "HDP") synthetase of Bacillus stearothermophilus origin, to DNA encoding the enzyme, to an expression vector containing the DNA, to a host transformed by the expression vector, to a method of producing heptaprenyl diphosphate-synthesizing enzyme by the host, and to a method of producing heptaprenyl diphosphate using the enzyme or host.
  • HDP heptaprenyl diphosphate
  • HDP synthesized from condensation reaction of 4 molecules of isopentenyl diphosphate and 1 molecule of farnesyl diphosphate by HDP-synthetase, is an important: biosynthetic intermediate of isoprenoids such as prenylquinone.
  • HDP-synthetase which is categorized into prenyl transferase, is known to be present in some microorganisms such as Bacillus subtilis (J. Biol. Chem. 255, p.4539-4543 (1980)), its amino acid sequence and the DNA sequence of the gene encoding it have not been known.
  • the present invention is aimed at providing HDP synthetase of Bacillus stearothermophilus origin, which was hitherto unknown in the species, DNA encoding the enzyme, and a method of production of the recombinant HDP synthetase using the DNA.
  • the present inventors have been the first to succeed in cloning an HDP synthetase gene of Bacillus stearothermophilus origin, by the PCR method using synthesized primers designed from a portion of the known sequence of prenyl transferase, following hybridization using PCR amplified fragments as probe and measuring the expressed activity of the gene expression products.
  • the present invention provides a protein of Bacillus stearothermophilus origin having heptaprenyl diphosphate synthetase activity, which comprises a peptide with the amino acid sequence from the 1st amino acid Met to the 220th amino acid Gly of Sequence No. 1, (SEQ ID NO.1) or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence; a peptide with the amino acid sequence from the 1st amino acid Met to the 234th amino acid Arg of Sequence No. 2, (SEQ.
  • the present invention also provides a peptide of Bacillus stearothermophilus origin, which has the amino acid sequence from the 1st amino acid Met to the 220th amino acid Gly of Sequence No. 1 (SEQ ID NO.1), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence.
  • the present invention further provides a peptide of Bacillus stearothermophilus origin, which has the amino acid sequence from the 1st amino acid Val to the 323rd amino acid Tyr of Sequence No. 3 (SEQ ID NO.3), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence.
  • the present invention further provides a protein of Bacillus stearothermophilus origin with heptaprenyl diphosphate synthetase activity, which comprises a peptide with the amino acid sequence from the 1st amino acid Met to the 220th amino acid Gly of Sequence No. 1 (SEQ. ID NO.1), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence; and a peptide with the amino acid sequence from the 1st amino acid Val to the 323rd amino acid Tyr of Sequence No. 3 (SEQ ID NO.3), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence.
  • a protein of Bacillus stearothermophilus origin with heptaprenyl diphosphate synthetase activity which comprises a peptide with the amino acid sequence from the 1st amino acid Met to the 220th amino acid Gly of Sequence No. 1 (
  • the present invention further provides a protein of Bacillus stearothermophilus origin with heptaprenyl diphosphate synthetase activity, which comprises a peptide with the amino acid sequence from the 1st amino acid Met to the 220th amino acid Gly of Sequence No. 1 (SEQ ID NO.1), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence; and a peptide with the amino acid sequence from the 1st amino acid Met to the 234th amino acid Arg of Sequence No. 2 (SEQ ID NO.2), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence.
  • a protein of Bacillus stearothermophilus origin with heptaprenyl diphosphate synthetase activity which comprises a peptide with the amino acid sequence from the 1st amino acid Met to the 220th amino acid Gly of Sequence No. 1 (S
  • the present invention further provides a protein of Bacillus stearothermophilus origin with heptaprenyl diphosphate synthetase activity, which comprises a peptide with the amino acid sequence from the 1st amino acid Met to the 234th amino acid Arg of Sequence No. 2 (SEQ ID NO.2), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence; and a peptide with the amino acid sequence from the 1st amino acid Val to the 323rd amino acid Tyr of Sequence No. 3 (SEQ ID NO.3), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence.
  • a protein of Bacillus stearothermophilus origin with heptaprenyl diphosphate synthetase activity which comprises a peptide with the amino acid sequence from the 1st amino acid Met to the 234th amino acid Arg of Sequence No. 2 (S
  • the present invention further provides DNA encoding the above-mentioned protein and various peptides.
  • the present invention further provides an expression vector comprising the above-mentioned DNA.
  • the present invention further provides a host transformed by the above-mentioned expression vector.
  • the present invention further provides a method of producing heptaprenyl diphosphate synthetase which is characterized by culturing the above-mentioned host, and collecting heptaprenyl diphosphate synthetase from the cultured product.
  • the present invention further provides a method of producing heptaprenyl diphosphate which is characterized by culturing the above-mentioned transformant, and collecting heptaprenyl diphosphate from the cultured product.
  • the present invention further provides a method of producing heptaprenyl diphosphate which is characterized by reacting the above-mentioned enzyme with a substrate.
  • FIG. 1 shows the positional relationships and restriction enzyme maps for plasmids pAC2, pPR2, pTL6, pTLD9, pTLD17 and pTLD7 of the present invention.
  • FIG. 2 is a thin layer radiochromatigram of the reaction mixture prepared by incubation of isopentenyl diphospate and farnesyl diphosphate with expression product of a DNA fragment of the present invention.
  • the open reading frame portions of nucleotide sequences of DNA cloned from Bacillus stearothermophilus which express heptaprenyl diphosphate synthetase activity are shown as SEQ ID NOS.1 to 3.
  • ORF open reading frames
  • the first open reading frame (ORFI) is assumed to begin at the ATG coding for the 1st amino acid Met of SEQ ID NO.1 and to end with the GGG coding for the 220th Gly. However, it may possibly begin at the ATG coding for the 19th amino acid Met, the ATG coding for the 20th amino acid Met, or the ATG coding for the 22nd amino acid Met.
  • the second open reading frame (ORFII) is assumed to begin at the ATG coding for the 1st amino acid Met of SEQ ID NO.2 and to end with the CGG coding for the 234th amino acid Arg. However, this ORFII may possibly begin at the ATG coding for the 23rd amino acid Met of the amino acid sequence.
  • the third open reading frame (ORFIII) is assumed to begin at the GTG coding for the 1st amino acid Val of SEQ ID NO.3, and to end with the TAT coding for the 323rd amino acid Tyr. However, this ORFIII may possibly begin at the ATG coding for the 4th amino acid Met or the ATG coding for the 9th amino acid Met.
  • nucleotide AACG is located between the translation termination codon TAG at the 3' end of ORFI and the translation initiation codon ATG (Met) of ORFII
  • nucleotide GTTAAG is located between the translation termination codon TGA of ORFII and the translation initiation codon GTG (Val) of ORFIII.
  • DNA comprising all of ORFI, ORFII and ORFIII, heptaprenyl diphosphate synthetase consisting of the peptide encoded thereby, and a method for its production.
  • the present invention also provides DNA containing ORFI and ORFIII but not containing ORFII in its complete form, a peptide having heptaprenyl diphosphate synthetase activity which is expressed by that DNA, and a method for its production.
  • the present invention further provides DNA containing ORFI and ORFII, or ORFII and ORFIII but not containing any other ORF in its complete form, a peptide expressed thereby, and a method for its production.
  • Plant-derived enzymes sometimes differ in a few amino acids depending on the variety of plants from which they are derived, and often differ in a few amino acids by natural mutations.
  • the native activity of an enzyme is sometimes maintained even upon artificial mutation on the amino acid sequence. Consequently, the present invention also encompasses, in addition to peptides having the amino acid sequences represented by SEQ ID NOS.1 to 3, also peptides with amino acid sequences resulting from variations of the amino acid sequences represented by SEQ ID NOS.1 to 3 by means of a substitution, deletion and/or addition of one or a few, for example 5 or 10, amino acids, providing that the peptides are still have the enzyme activity.
  • the present invention further provides DNA encoding a peptide mutated in the manner described above, as well as a method of producing the mutated peptide.
  • the DNA of the present invention may be cloned from Bacillus stearothermophilus.
  • ORFIII, ORFI and ORFII or ORFII and ORFIII, and not containing any other ORF in its complete form may be obtained by cutting full-length DNA using restriction endonucleases which cut within, for example, other ORFs outside of the aimed ORF without cutting within the latter.
  • DNA encoding a mutated peptide may be obtained by the site-specific mutagenesis using, for example, a mutagenic primer.
  • each individual ORF of the present invention is not especially long, and thus may be easily synthesized by a person skilled in the art by conventional DNA synthesis methods.
  • the present invention further provides expression vectors comprising the DNA as described above, hosts transformed by the expression vectors, and a method of producing the enzyme or peptides of the present invention using these hosts.
  • the expression vector includes an origin of replication, the expression regulating sequence, etc., which differ depending on the host.
  • the host may be a prokaryotic organism, for example a bacterium such as an E. coli, or Bacillus such as Bacillus subtilis; a eukaryotic organism, for example yeast, a fungus an example of which is S. cerevisiae belonging to the genus Saccharomyces, or fungus an example of which is a mold such as A. niger or A. oryzae belonging to the genus Aspergillus; animal cells such as cultured silk worm cells or cultured higher animal cells, for example CHO cells. Plant cells may also be used as hosts.
  • heptaprenyl diphosphate synthase by culturing a host transformed with DNA of the present invention, which accumulates the enzyme in the culture, and recovering it.
  • heptaprenyl diphosphate may also be produced by allowing HDP synthetase produced by the method of the present invention to react with isopentenyl diphosphate and allylic diphosphate such as farnesyl diphosphate acid as substrates.
  • E. coli as a host for an example, there are known gene expression regulating mechanism in the process of transcription of mRNA from DNA, the process of translation of protein from mRNA, etc.
  • promoter sequences which regulate mRNA synthesis there are known, in addition to naturally occurring sequences (for example, lac, trp, bla, lpp, P L , P R , ter, T3, T7, etc.), also mutants thereof (for example, lacUV5) and sequences obtained by artificially fusing natural promoter sequences (for example, tac, trc, etc.), and these may also be used according to the present invention.
  • sequences capable of regulating ability to synthesize protein from mRNA As sequences capable of regulating ability to synthesize protein from mRNA, the importance of the ribosome-binding site (GAGG and similar sequences) and the distance to the initiation codon ATG is already known. It is also well known that terminator sequences which govern completion of transcription at the 3' end (for example, vectors including rrnBT 1 T 2 are commercially available from Pharmacia Co.) affect the efficiency of protein synthesis in recombinants.
  • Vectors which may be used to prepare the recombinant vectors of the present invention may be commercially available ones, or they may be any of a variety of derived vectors, depending on the purpose.
  • pBR322, pBR327, pKK223-3, pKK233-2, pTrc99, etc. which carry the pMB1-derived replicon
  • pUC18, pUC19, pUC118, pUC119, pHSG298, pHSG396, etc. which have been modified for increased number of copies
  • pACYC177, pACYC184, etc. which carry the p15A-derived replicon
  • plasmids derived from pSC101, ColE1, R1 or F factor plasmids derived from pSC101, ColE1, R1 or F factor.
  • gene introduction is also possible by way of virus vectors such as ⁇ -phage and M13 phage, and transposons.
  • virus vectors such as ⁇ -phage and M13 phage, and transposons.
  • pUB110 available from Sigma Co.
  • pHY300PLK available from Takara Shuzo.
  • pTrc99 (available from Pharmacia Co.) is preferred as a vector including, in addition to the ampicillin resistance gene as a selective marker, Ptrc and lacI q as a promoter and controlling gene, the sequence AGGA as a ribosome-binding site, and rrnBT 1 T 2 as the terminator, and having an expression regulating function on the HDP-synthesizing enzyme gene.
  • a DNA fragment coding for HDP synthetase and if necessary a DNA fragment with the function of expression regulation on the gene for the above-mentioned enzyme may be accomplished by a known method using an appropriate restriction endonuclease and ligase. Specifically the method described below may be conveniently followed.
  • pTL6 may be mentioned as a definite plasmid of the present invention prepared in this manner.
  • microorganisms for the gene introduction by such recombinant vectors there may be used Escherichia coli, as well as microorganisms belonging to the genus Bacillus.
  • the transformation may also be carried out by a conventional method, for example the CaCl 2 method or protoplast method described in Molecular Cloning (J. Sambrook, E. F. Fritsch, T. Maniatis, published by Cold Spring Harbor Laboratory Press) or DNA Cloning Vol. I-III (ed. by D. M. Glover, published by IRL PRESS), etc.
  • a representative transformant according to the present invention which may be obtained is pTL6/JM109.
  • HDP synthase heptaprenyl diphosphate synthase
  • Lysozyme is preferably used as the cytolytic enzyme, and ultrasonic waves are preferably used for physical treatment. Most of the E. coli-derived protein may be removed as insoluble deposit by heating at about 55° C.
  • any or a combination of gel filtration, ion exchange, hydrophobic, reverse phase, affinity or other type of chromatography, or ultrafiltration may be available.
  • a reagent to stabilize the desired enzyme may be combined with the treatment solution, for example, a reducing agent such as ⁇ -mercaptoethanol or dithiothreitol, protective agent against proteases, such as PMSF or BSA, or metal ion such as magnesium.
  • a reducing agent such as ⁇ -mercaptoethanol or dithiothreitol
  • protective agent against proteases such as PMSF or BSA
  • metal ion such as magnesium
  • HDP synthetase activity may be measured, for example, in the manner described hereunder, it is recommended that the isolation and purification of the enzyme be performed while confirming the activity of the enzyme using the assay reaction solution employed in f) in Example 1 hereunder.
  • the experiment was carried out basically in accordance with Molecular Cloning, DNA Cloning and the Takara Shuzo Catalog, mentioned previously. Most of the enzymes used were purchased from Takara Shuzo.
  • the Bacillus stearothermophilus used was the known bacterium stored at the American Type Culture Collection (ATCC). Strain ATCC 10149 was used for this experiment.
  • Culturing was performed in LB medium (1% tryptone, 0.5% yeast extract, 1% NaCl) at 55° C., and the cells were collected. After suspension in a lysis buffer, lysozyme (chicken albumen-derived, product of Sigma Co.) was added to 10 mg/ml. After lysis, 1/10 volume of 1M Tris•HCl (pH 8.0), 1/10 volume of 10% SDS and 1/50 volume of 5 M NaCl were added. Proteinase K (product of Sigma Co.) was added to 10 mg/ml, and the mixture was heated to 50° C.
  • lysozyme chicken albumen-derived, product of Sigma Co.
  • the chromosomal DNA was subjected to partial digestion with Sau3AI, and the PCR (polymerase chain reaction) was conducted with combinations of synthetic DNA P1 and P4, P1 and P6, P1 and P8, P2 and P4, P2 and P6, P2 and P8, P9 and P11, P9 and P4, P9 and P6, P9 and P8, P9 and P13, P1 and P11, P2 and P11, P12 and P4, P12 and P6, P12 and P8, P12 and P13, P1 and P13, P2 and P13, P10 and P4, P10 and p6, P10 and P8, and P10 and P13.
  • the PCR product of the P10 and P8 combination was linked with the HincII digestion product of plasmid pUC118 (purchased from Takara Shuzo) using T4DNA ligase, and E. coli JM109 was transformed. Plasmids were prepared by the alkali SDS method, and the DNA sequences of 27 clones were analyzed with an Applied Biosystems 373A fluorescent DNA sequencer. One of the sequences was referred as pCR64.
  • c-1) A DNA fragment consisting of an approximately 500 bp pCR64 digestion product by restriction endonucleases KpnI and HindIII was labelled with DIG using a DIG DNA labeling kit (purchased from BOEHRINGER MANNHEIM). The instructions in the kit manual were followed.
  • the chromosomal DNA was digested with restriction endonuclease AccI, and upon Southern hybridization using the probe from c-1), a band was detected in the position of about 3 kbp.
  • the DNA fragment of about 3 kbp was isolated by agarose gel electrophoresis and treated with T4 DNA polymerase. These were linked with the SmaI digestion product of plasmid pUC18 using T4 DNA ligase, and E. coli JM109 was transformed.
  • the library prepared in c-2) was screened with the probe prepared in c-1). Detection was made using a DIG DNA detection kit (purchased from BOEHRINGER MANNHEIM) and plasmid pAC2 was obtained. The instructions in the kit manual were followed. DNA sequence of the inserted gene of about 2.5 kbp was analyzed with an Applied Biosystems 373A fluorescent sequencer.
  • the gene library of c-2) was subjected to PCR using a synthetic DNA primer P64-4 (Sequence No. 14 (SEQ ID NO.14)) prepared based on the DNA sequence obtained in c-3) and M13 Primer RV (purchased from Takara Shuzo).
  • the amplification product was inserted into pT7 Blue T-Vector (purchased from Novagen) to obtain pPR2.
  • the E. coli JM105 transformed with pTL6 was cultured overnight in 50 ml of LB medium containing 50 ⁇ g/ml of ampicillin, and the cells were collected. These were suspended in 4 ml of lysis buffer and disrupted with ultrasonic waves. Heating was performed at 55° C. for 1 hour to inactivate the E. coli-derived prenyl transferase, and the E. coli-derived denatured protein was removed by centrifugation and the supernatant was used for the assay. The assay reaction mixture was allowed to react for 1 hour or 14 hours at 55° C. The reaction mixture was extracted with 1-butanol, and the radioactivity was measured using a liquid scintillation counter.
  • the 1-butanol extract obtained from the above-mentioned reaction of JM105 carrying pTL6 was hydrolyzed and analyzed by thin-layer chromatography (TLC).
  • TLC thin-layer chromatography
  • E. coli normally has no heptaprenyl transferases or prenyl transferase with activity at 55° C.
  • E. coli transformed with pTL6 is able to synthesize heptaprenyl diphosphate. Also, the fact that the activity is present at 55° C. indicates that the Bacillus stearothermophilus-derived prenyl transferase encoded by pTL6 is highly thermostable. This also shows that the recombinant is useful for producing stable heptaprenyl diphosphate.
  • pTL6 had a gene insert of about 3 kbp, which contained three ORFs.
  • plasmid pTLD9 by deletion of ORFI
  • plasmid pTLD17 by deletion of OFRII
  • plasmid pTLD7 by deletion of ORFIII
  • activity was found for pTL6, pTLD9 and pTLD17.
  • 1-Butanol extracts of reaction products of pTL6 and pTLD17 were hydrolyzed and analyzed by TLC, and the produced isoprenoid was confirmed to be heptaprenyl diphosphate.
  • DNA sequences coding for heptaprenyl diphosphate synthetase enzyme of Bacillus stearothermophilus origin obtained by incorporating the DNA sequences into expression vectors which are then used to transform appropriate E. coli strains, produce safe substances with heptaprenyl diphosphate synthetase activity and heptaprenyl diphosphate.

Abstract

Heptaprenyl diphosphate (HDP)-synthetase derived from Bacillus stearothermophilus which enzymes have the amino acid sequences shown as SEQ ID NOs: 1 to 3; 1 and 2; 2 and 3; or 1 and 3, DNA encoding them, and a method of producing the enzymes.
According to the invention it is possible to industrially produce HDP-synthesizing enzyme and HPD.

Description

This is a division of application Ser. No. 08/506,404 filed Jul. 24, 1995 now U.S. Pat. No. 5,773,265.
BACKGROUND OF INVENTION
1. Field of Invention
The present invention relates to heptaprenyl diphosphate (hereunder sometimes abbreviated to "HDP") synthetase of Bacillus stearothermophilus origin, to DNA encoding the enzyme, to an expression vector containing the DNA, to a host transformed by the expression vector, to a method of producing heptaprenyl diphosphate-synthesizing enzyme by the host, and to a method of producing heptaprenyl diphosphate using the enzyme or host.
2. Related Art
HDP, synthesized from condensation reaction of 4 molecules of isopentenyl diphosphate and 1 molecule of farnesyl diphosphate by HDP-synthetase, is an important: biosynthetic intermediate of isoprenoids such as prenylquinone. Although HDP-synthetase, which is categorized into prenyl transferase, is known to be present in some microorganisms such as Bacillus subtilis (J. Biol. Chem. 255, p.4539-4543 (1980)), its amino acid sequence and the DNA sequence of the gene encoding it have not been known.
Genes coding for other prenyl transferase are known, farnesyl diphosphate synthetase ([2.5.1.1.] J. Biol. Chem. 265, p.4607-4614 (1990)), geranylgeranyl diphosphate synthetase (Proc. Natl. Acad. Sci. USA, 89, p.6761-6764). However, the tertiary structures of the known prenyl transferases are homodimers which comprise two identical subunits, and it is different from the peculiar heterodimer of Bacillus subtilis HDP synthetase (FEBS Lett. 161, 257-260 (1983)). Therefore, absolutely no data exists regarding homology between the amino acid sequences of the former two and the latter.
Consequently, the present invention is aimed at providing HDP synthetase of Bacillus stearothermophilus origin, which was hitherto unknown in the species, DNA encoding the enzyme, and a method of production of the recombinant HDP synthetase using the DNA.
SUMMARY OF INVENTION
With the aim of accomplishing the above-mentioned object, the present inventors have been the first to succeed in cloning an HDP synthetase gene of Bacillus stearothermophilus origin, by the PCR method using synthesized primers designed from a portion of the known sequence of prenyl transferase, following hybridization using PCR amplified fragments as probe and measuring the expressed activity of the gene expression products.
Thus, the present invention provides a protein of Bacillus stearothermophilus origin having heptaprenyl diphosphate synthetase activity, which comprises a peptide with the amino acid sequence from the 1st amino acid Met to the 220th amino acid Gly of Sequence No. 1, (SEQ ID NO.1) or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence; a peptide with the amino acid sequence from the 1st amino acid Met to the 234th amino acid Arg of Sequence No. 2, (SEQ. ID NO.2) or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence; and a peptide with the amino acid sequence from the 1st amino acid Val to the 323rd amino acid Tyr of Sequence No. 3 (SEQ ID NO.3), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence.
The present invention also provides a peptide of Bacillus stearothermophilus origin, which has the amino acid sequence from the 1st amino acid Met to the 220th amino acid Gly of Sequence No. 1 (SEQ ID NO.1), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence.
The present invention further provides a peptide of Bacillus stearothermophilus origin, which has the amino acid sequence from the 1st amino acid Val to the 323rd amino acid Tyr of Sequence No. 3 (SEQ ID NO.3), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence.
The present invention further provides a protein of Bacillus stearothermophilus origin with heptaprenyl diphosphate synthetase activity, which comprises a peptide with the amino acid sequence from the 1st amino acid Met to the 220th amino acid Gly of Sequence No. 1 (SEQ. ID NO.1), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence; and a peptide with the amino acid sequence from the 1st amino acid Val to the 323rd amino acid Tyr of Sequence No. 3 (SEQ ID NO.3), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence.
The present invention further provides a protein of Bacillus stearothermophilus origin with heptaprenyl diphosphate synthetase activity, which comprises a peptide with the amino acid sequence from the 1st amino acid Met to the 220th amino acid Gly of Sequence No. 1 (SEQ ID NO.1), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence; and a peptide with the amino acid sequence from the 1st amino acid Met to the 234th amino acid Arg of Sequence No. 2 (SEQ ID NO.2), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence.
The present invention further provides a protein of Bacillus stearothermophilus origin with heptaprenyl diphosphate synthetase activity, which comprises a peptide with the amino acid sequence from the 1st amino acid Met to the 234th amino acid Arg of Sequence No. 2 (SEQ ID NO.2), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence; and a peptide with the amino acid sequence from the 1st amino acid Val to the 323rd amino acid Tyr of Sequence No. 3 (SEQ ID NO.3), or an amino acid sequence resulting from a substitution, deletion or addition of one or a few amino acids in the amino acid sequence.
The present invention further provides DNA encoding the above-mentioned protein and various peptides.
The present invention further provides an expression vector comprising the above-mentioned DNA.
The present invention further provides a host transformed by the above-mentioned expression vector.
The present invention further provides a method of producing heptaprenyl diphosphate synthetase which is characterized by culturing the above-mentioned host, and collecting heptaprenyl diphosphate synthetase from the cultured product.
The present invention further provides a method of producing heptaprenyl diphosphate which is characterized by culturing the above-mentioned transformant, and collecting heptaprenyl diphosphate from the cultured product.
The present invention further provides a method of producing heptaprenyl diphosphate which is characterized by reacting the above-mentioned enzyme with a substrate.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows the positional relationships and restriction enzyme maps for plasmids pAC2, pPR2, pTL6, pTLD9, pTLD17 and pTLD7 of the present invention.
FIG. 2 is a thin layer radiochromatigram of the reaction mixture prepared by incubation of isopentenyl diphospate and farnesyl diphosphate with expression product of a DNA fragment of the present invention.
DETAILED DESCRIPTION
The open reading frame portions of nucleotide sequences of DNA cloned from Bacillus stearothermophilus which express heptaprenyl diphosphate synthetase activity are shown as SEQ ID NOS.1 to 3. There are 3 open reading frames (ORF). The first open reading frame (ORFI) is assumed to begin at the ATG coding for the 1st amino acid Met of SEQ ID NO.1 and to end with the GGG coding for the 220th Gly. However, it may possibly begin at the ATG coding for the 19th amino acid Met, the ATG coding for the 20th amino acid Met, or the ATG coding for the 22nd amino acid Met.
The second open reading frame (ORFII) is assumed to begin at the ATG coding for the 1st amino acid Met of SEQ ID NO.2 and to end with the CGG coding for the 234th amino acid Arg. However, this ORFII may possibly begin at the ATG coding for the 23rd amino acid Met of the amino acid sequence. The third open reading frame (ORFIII) is assumed to begin at the GTG coding for the 1st amino acid Val of SEQ ID NO.3, and to end with the TAT coding for the 323rd amino acid Tyr. However, this ORFIII may possibly begin at the ATG coding for the 4th amino acid Met or the ATG coding for the 9th amino acid Met.
In the DNA containing the cloned ORFI-III, the nucleotide AACG is located between the translation termination codon TAG at the 3' end of ORFI and the translation initiation codon ATG (Met) of ORFII, and the nucleotide GTTAAG is located between the translation termination codon TGA of ORFII and the translation initiation codon GTG (Val) of ORFIII.
The full-length DNA expression product had the strongest heptaprenyl diphosphate synthetase activity and the expression products of ORFI and ORFIII, ORFI and ORFII, and ORFII and ORFIII also showed heptaprenyl diphosphate synthetase activity. Consequently, according to one embodiment of the present invention, there are provided DNA comprising all of ORFI, ORFII and ORFIII, heptaprenyl diphosphate synthetase consisting of the peptide encoded thereby, and a method for its production.
The present invention also provides DNA containing ORFI and ORFIII but not containing ORFII in its complete form, a peptide having heptaprenyl diphosphate synthetase activity which is expressed by that DNA, and a method for its production. The present invention further provides DNA containing ORFI and ORFII, or ORFII and ORFIII but not containing any other ORF in its complete form, a peptide expressed thereby, and a method for its production.
Plant-derived enzymes sometimes differ in a few amino acids depending on the variety of plants from which they are derived, and often differ in a few amino acids by natural mutations. In addition, the native activity of an enzyme is sometimes maintained even upon artificial mutation on the amino acid sequence. Consequently, the present invention also encompasses, in addition to peptides having the amino acid sequences represented by SEQ ID NOS.1 to 3, also peptides with amino acid sequences resulting from variations of the amino acid sequences represented by SEQ ID NOS.1 to 3 by means of a substitution, deletion and/or addition of one or a few, for example 5 or 10, amino acids, providing that the peptides are still have the enzyme activity.
The present invention further provides DNA encoding a peptide mutated in the manner described above, as well as a method of producing the mutated peptide.
As will be explained in detail by way of the examples, the DNA of the present invention may be cloned from Bacillus stearothermophilus. Also, DNA containing any one of ORFI, ORFII and ORFIII, all three, or ORFI and. ORFIII, ORFI and ORFII or ORFII and ORFIII, and not containing any other ORF in its complete form, may be obtained by cutting full-length DNA using restriction endonucleases which cut within, for example, other ORFs outside of the aimed ORF without cutting within the latter. Alternatively, DNA encoding a mutated peptide may be obtained by the site-specific mutagenesis using, for example, a mutagenic primer.
Furthermore, once the amino acid sequence of one peptide is determined, it is possible to define a proper nucleotide sequence coding therefor, which then allows chemical synthesis of the DNA by conventional DNA synthesis methods. Each individual ORF of the present invention is not especially long, and thus may be easily synthesized by a person skilled in the art by conventional DNA synthesis methods.
The present invention further provides expression vectors comprising the DNA as described above, hosts transformed by the expression vectors, and a method of producing the enzyme or peptides of the present invention using these hosts.
The expression vector includes an origin of replication, the expression regulating sequence, etc., which differ depending on the host. The host may be a prokaryotic organism, for example a bacterium such as an E. coli, or Bacillus such as Bacillus subtilis; a eukaryotic organism, for example yeast, a fungus an example of which is S. cerevisiae belonging to the genus Saccharomyces, or fungus an example of which is a mold such as A. niger or A. oryzae belonging to the genus Aspergillus; animal cells such as cultured silk worm cells or cultured higher animal cells, for example CHO cells. Plant cells may also be used as hosts.
According to the present invention, as will be shown in the examples, it is possible to produce heptaprenyl diphosphate synthase by culturing a host transformed with DNA of the present invention, which accumulates the enzyme in the culture, and recovering it. Also, according to the present invention, heptaprenyl diphosphate may also be produced by allowing HDP synthetase produced by the method of the present invention to react with isopentenyl diphosphate and allylic diphosphate such as farnesyl diphosphate acid as substrates.
Referring to the use of E. coli as a host for an example, there are known gene expression regulating mechanism in the process of transcription of mRNA from DNA, the process of translation of protein from mRNA, etc. As promoter sequences which regulate mRNA synthesis, there are known, in addition to naturally occurring sequences (for example, lac, trp, bla, lpp, PL, PR, ter, T3, T7, etc.), also mutants thereof (for example, lacUV5) and sequences obtained by artificially fusing natural promoter sequences (for example, tac, trc, etc.), and these may also be used according to the present invention.
As sequences capable of regulating ability to synthesize protein from mRNA, the importance of the ribosome-binding site (GAGG and similar sequences) and the distance to the initiation codon ATG is already known. It is also well known that terminator sequences which govern completion of transcription at the 3' end (for example, vectors including rrnBT1 T2 are commercially available from Pharmacia Co.) affect the efficiency of protein synthesis in recombinants.
Vectors which may be used to prepare the recombinant vectors of the present invention may be commercially available ones, or they may be any of a variety of derived vectors, depending on the purpose. As examples there may be mentioned pBR322, pBR327, pKK223-3, pKK233-2, pTrc99, etc. which carry the pMB1-derived replicon; pUC18, pUC19, pUC118, pUC119, pHSG298, pHSG396, etc. which have been modified for increased number of copies; pACYC177, pACYC184, etc. which carry the p15A-derived replicon; and plasmids derived from pSC101, ColE1, R1 or F factor.
In addition to plasmids, gene introduction is also possible by way of virus vectors such as λ-phage and M13 phage, and transposons. For gene introduction to microorganisms other than E. coli, there is known gene introduction to the genus Bacillus by pUB110 (available from Sigma Co.) and pHY300PLK (available from Takara Shuzo). These vectors are described in Molecular Cloning (J. Sambrook, E. F. Fritsch, T. Maniatis, published by Cold Spring Harbor Laboratory Press), Cloning Vector (P. H. Pouwels, B. E. Enger/Valk, W. J. Brammar, published by Elsevier), and various company catalogs.
In particular, pTrc99 (available from Pharmacia Co.) is preferred as a vector including, in addition to the ampicillin resistance gene as a selective marker, Ptrc and lacIq as a promoter and controlling gene, the sequence AGGA as a ribosome-binding site, and rrnBT1 T2 as the terminator, and having an expression regulating function on the HDP-synthesizing enzyme gene.
The incorporation into these vectors of a DNA fragment coding for HDP synthetase and if necessary a DNA fragment with the function of expression regulation on the gene for the above-mentioned enzyme, may be accomplished by a known method using an appropriate restriction endonuclease and ligase. Specifically the method described below may be conveniently followed. pTL6 may be mentioned as a definite plasmid of the present invention prepared in this manner.
As microorganisms for the gene introduction by such recombinant vectors, there may be used Escherichia coli, as well as microorganisms belonging to the genus Bacillus. The transformation may also be carried out by a conventional method, for example the CaCl2 method or protoplast method described in Molecular Cloning (J. Sambrook, E. F. Fritsch, T. Maniatis, published by Cold Spring Harbor Laboratory Press) or DNA Cloning Vol. I-III (ed. by D. M. Glover, published by IRL PRESS), etc.
A representative transformant according to the present invention which may be obtained is pTL6/JM109.
When these transformants or recombinant microorganism cells are cultured in medium normally used for E. coli, heptaprenyl diphosphate synthase (HDP synthase) accumulates in the cells. The HDP in the cells may be recovered by physical treatment in the absence or presence of a cytolytic enzyme for lysis and a conventional isolation and purification method for enzymes.
Lysozyme is preferably used as the cytolytic enzyme, and ultrasonic waves are preferably used for physical treatment. Most of the E. coli-derived protein may be removed as insoluble deposit by heating at about 55° C. For the isolation and purification of the enzyme, any or a combination of gel filtration, ion exchange, hydrophobic, reverse phase, affinity or other type of chromatography, or ultrafiltration may be available.
During the process of isolation and purification, a reagent to stabilize the desired enzyme may be combined with the treatment solution, for example, a reducing agent such as β-mercaptoethanol or dithiothreitol, protective agent against proteases, such as PMSF or BSA, or metal ion such as magnesium.
Since the above-mentioned HDP synthetase activity may be measured, for example, in the manner described hereunder, it is recommended that the isolation and purification of the enzyme be performed while confirming the activity of the enzyme using the assay reaction solution employed in f) in Example 1 hereunder.
EXAMPLES
An example of a method of preparing a DNA sequence, plasmid and transformant according to the present invention will now be described, but the scope of the invention is in no way restricted to this example.
Example 1
The experiment was carried out basically in accordance with Molecular Cloning, DNA Cloning and the Takara Shuzo Catalog, mentioned previously. Most of the enzymes used were purchased from Takara Shuzo. The Bacillus stearothermophilus used was the known bacterium stored at the American Type Culture Collection (ATCC). Strain ATCC 10149 was used for this experiment.
a) Preparation of Chromosomal DNA of Bacillus stearothermophilus
Culturing was performed in LB medium (1% tryptone, 0.5% yeast extract, 1% NaCl) at 55° C., and the cells were collected. After suspension in a lysis buffer, lysozyme (chicken albumen-derived, product of Sigma Co.) was added to 10 mg/ml. After lysis, 1/10 volume of 1M Tris•HCl (pH 8.0), 1/10 volume of 10% SDS and 1/50 volume of 5 M NaCl were added. Proteinase K (product of Sigma Co.) was added to 10 mg/ml, and the mixture was heated to 50° C.
An equivalent of phenol was added and the mixture stirred and centrifuged to remove the protein. The supernatant was taken with a wide-mouthed pipette into a beaker, and after a 2.5-fold amount of ethanol was gently layered thereon the chromosomal DNA was wound up on a glass rod. After dissolution in TE (10 mM Tris•HCl (pH 8.0), 1 mM EDTA), the DNA was treated with RNaseA (product of Sigma Co.), Proteinase K and phenol, a 2.5-fold amount of ethanol was gently layered thereon and the chromosomal DNA was wound up on a glass rod. After washing with 70% ethanol, it was dissolved in TE and used in the following experiment.
b) Acquisition of pCR64
DNA primers P1 (Sequence No. 4 (SEQ ID NO.4)), P2 (Sequence No. 5 (SEQ ID NO.5)), P4 (Sequence No. 6 (SEQ ID NO.6)), P6 (Sequence No. 7 (SEQ ID NO.7)), P8 (Sequence No. 8 (SEQ ID NO.8)), P9 (Sequence No. 9 (SEQ ID NO.9)), P10 (Sequence No. 10 (SEQ ID NO.10)), P11 (Sequence No. 11 (SEQ ID NO.11)), P12 (Sequence No. 12 (SEQ ID NO.12) and P13 (Sequence No. 13 (SEQ ID NO.13)) were prepared based on the heretofore known conserved regions of the amino acid sequence of prenyl transferase.
The chromosomal DNA was subjected to partial digestion with Sau3AI, and the PCR (polymerase chain reaction) was conducted with combinations of synthetic DNA P1 and P4, P1 and P6, P1 and P8, P2 and P4, P2 and P6, P2 and P8, P9 and P11, P9 and P4, P9 and P6, P9 and P8, P9 and P13, P1 and P11, P2 and P11, P12 and P4, P12 and P6, P12 and P8, P12 and P13, P1 and P13, P2 and P13, P10 and P4, P10 and p6, P10 and P8, and P10 and P13.
The PCR product of the P10 and P8 combination was linked with the HincII digestion product of plasmid pUC118 (purchased from Takara Shuzo) using T4DNA ligase, and E. coli JM109 was transformed. Plasmids were prepared by the alkali SDS method, and the DNA sequences of 27 clones were analyzed with an Applied Biosystems 373A fluorescent DNA sequencer. One of the sequences was referred as pCR64.
              TABLE 1                                                     
______________________________________                                    
(Composition of PCR reaction solution)                                    
    Template DNA             1 μg                                      
                              10 × Amplitaq Buffer 10 μ1         
                              dNTPs mixture solution (1.25 mM each) 16    
                             μ1                                        
  Primer 1 100 pmol                                                       
  Primer 2 100 pmol                                                       
  Taq polymerase adjusted to 100 μl with H.sub.2 O 2 units             
  (PCR reaction conditions)                                               
94° C., 30 secs                                                    
  ↓                                                                
  50° C., 30 secs   × 35 cycles                              
  ↓                                                                
  72° C., 1 min                                                    
  ↓                                                                
  72° C., 7 mins                                                   
  ↓                                                                
  4° C.                                                            
______________________________________
c) Cloning of Surrounding Region With pCR64 as Probe
c-1) A DNA fragment consisting of an approximately 500 bp pCR64 digestion product by restriction endonucleases KpnI and HindIII was labelled with DIG using a DIG DNA labeling kit (purchased from BOEHRINGER MANNHEIM). The instructions in the kit manual were followed.
c-2) Preparation of Library
The chromosomal DNA was digested with restriction endonuclease AccI, and upon Southern hybridization using the probe from c-1), a band was detected in the position of about 3 kbp. Here, the DNA fragment of about 3 kbp was isolated by agarose gel electrophoresis and treated with T4 DNA polymerase. These were linked with the SmaI digestion product of plasmid pUC18 using T4 DNA ligase, and E. coli JM109 was transformed.
c-3) Screening
The library prepared in c-2) was screened with the probe prepared in c-1). Detection was made using a DIG DNA detection kit (purchased from BOEHRINGER MANNHEIM) and plasmid pAC2 was obtained. The instructions in the kit manual were followed. DNA sequence of the inserted gene of about 2.5 kbp was analyzed with an Applied Biosystems 373A fluorescent sequencer.
d) Isolation of pPR2
The gene library of c-2) was subjected to PCR using a synthetic DNA primer P64-4 (Sequence No. 14 (SEQ ID NO.14)) prepared based on the DNA sequence obtained in c-3) and M13 Primer RV (purchased from Takara Shuzo). The amplification product was inserted into pT7 Blue T-Vector (purchased from Novagen) to obtain pPR2.
e) Linking of pAC2 and pPR2
DNA fragments of about 1 kbp and 5 kbp as BamHI digestion products of pAC2 and pPR2, respectively, were ligated to obtain pTL6.
f) Measurement of Isoprenoid Synthetase Activity
The E. coli JM105 transformed with pTL6 was cultured overnight in 50 ml of LB medium containing 50 μg/ml of ampicillin, and the cells were collected. These were suspended in 4 ml of lysis buffer and disrupted with ultrasonic waves. Heating was performed at 55° C. for 1 hour to inactivate the E. coli-derived prenyl transferase, and the E. coli-derived denatured protein was removed by centrifugation and the supernatant was used for the assay. The assay reaction mixture was allowed to react for 1 hour or 14 hours at 55° C. The reaction mixture was extracted with 1-butanol, and the radioactivity was measured using a liquid scintillation counter.
              TABLE 2                                                     
______________________________________                                    
(Composition of lysis buffer)                                             
    Tris.HCl (pH 7.7)         50 mM                                       
  EDTA 1 mM                                                               
  β-Mercaptoethanol 10 mM                                            
  PMSF 0.1 mM                                                             
  (Composition of assay reaction solution                                 
  (total volume: 1 ml))                                                   
  Tris.HCl (pH 8.5) 50 mM                                                 
  MgCl.sub.2 25 mM                                                        
  NH.sub.4 Cl 50 mM                                                       
  β-Mercaptoethanol 50 mM                                            
  (all-E)-farnesyl diphosphate 25 nmoles                                  
  [1-.sup.14 C]Isopentenyl diphosphate 25 nmoles                          
  (product of Amersham Col., corresponding to                             
  approx. 5.5 × 10.sup.4 dpm)                                       
  Cell-free extract 500 μl                                             
______________________________________
The 1-butanol extract obtained from the above-mentioned reaction of JM105 carrying pTL6 was hydrolyzed and analyzed by thin-layer chromatography (TLC). As a result, the produced isoprenoid was identified as heptaprenyl diphosphate, thus showing that pTL6 contains the gene for heptaprenyl diphosphate synthetase (FIG. 2). Furthermore, upon investigating the specificity to allylic substrate primers in the assay system described hereunder (Table 3), particular enzyme activity was found with (all-E) farnesyl diphosphate and (all-E) geranylgeranyl diphosphate, whereas dimethylallyl diphosphate, geranyl diphosphate, (2Z, 6E)-farnesyl diphosphate, (2Z, 6E, 10E) geranylgeranyl diphosphate and (2Z, 6E, 10E, 14E) farnesylgeranyl diphosphate were not satisfactory substrates (Table 4).
              TABLE 3                                                     
______________________________________                                    
(Composition of assay reaction solution                                   
  (total volume: 1 ml))                                                   
______________________________________                                    
Tris.HCl (pH 8.5)        50 mM                                            
  MgCl.sub.2 25 mM                                                        
  NH.sub.4 Cl 50 mM                                                       
  β-Mercaptoethanol 50 mM                                            
  Allylic substrate 2.5 nmoles                                            
  [1-.sup.14 C]Isopentenyl diphosphate 0.92 nmoles                        
  (product of Amersham Col., corresponding to                             
  approx. 1.1 × 10.sup.5 dpm)                                       
  Cell-free extract 500 μl                                             
______________________________________                                    

              TABLE 4                                                     
______________________________________                                    
Substrate specificity of HDP synthetase derived from                      
  DNA sequence of the present invention                                   
                          Enzyme                                          
  Substrate activity (dpm)                                                
______________________________________                                    
Dimethylallyl diphosphate                                                 
                      324                                                 
  Geranyl diphosphate 381                                                 
  (all-E) Farnesyl diphosphate 4163                                       
  (2Z, 6E) Farnesyl diphosphate 323                                       
  (all-E) Geranylgeranyl diphosphate 1514                                 
  (2Z, 6E, 10E) Geranylgeranyl diphosphate 648                            
  (all-E) Farnesylgeranyl diphosphate 728                                 
  (2Z, 6E, 10E, 14E) Farnesylgeranyl 281                                  
  diphosphate                                                             
______________________________________
E. coli normally has no heptaprenyl transferases or prenyl transferase with activity at 55° C. E. coli transformed with pTL6 is able to synthesize heptaprenyl diphosphate. Also, the fact that the activity is present at 55° C. indicates that the Bacillus stearothermophilus-derived prenyl transferase encoded by pTL6 is highly thermostable. This also shows that the recombinant is useful for producing stable heptaprenyl diphosphate.
g) Preparation of pTL6 Deletion Mutants and Identification of HDP Synthetase Gene
pTL6 had a gene insert of about 3 kbp, which contained three ORFs. Upon cleavage of pTL6 with restriction endonuclease and preparation of plasmid pTLD9 by deletion of ORFI, plasmid pTLD17 by deletion of OFRII and plasmid pTLD7 by deletion of ORFIII, and measurement of the isoprenoid-synthetase activities, activity was found for pTL6, pTLD9 and pTLD17. 1-Butanol extracts of reaction products of pTL6 and pTLD17 were hydrolyzed and analyzed by TLC, and the produced isoprenoid was confirmed to be heptaprenyl diphosphate.
              TABLE 5                                                     
______________________________________                                    
HDP synthetase activities derived from DNA sequences                      
  of the present invention (Radioactivity of 1-butanol                    
  extracts expressed in dpm units)                                        
    Cell-free extract solution                                            
                       Enzyme activity (dpm)                              
______________________________________                                    
E. coli JM105      0                                                      
  E. coli JM105/pT7Blue T-Vector 0                                        
  E. coli JM105/pTL6 750                                                  
  E. coli JM105/pTLD9 16                                                  
  E. coli JM105/pTLD17 129(*)                                             
  E. coli JM105/pTLD7 0                                                   
______________________________________                                    
 * = 14 hour reaction
According to the present invention there are provided DNA sequences coding for heptaprenyl diphosphate synthetase enzyme of Bacillus stearothermophilus origin.. Recombinant microorganisms, obtained by incorporating the DNA sequences into expression vectors which are then used to transform appropriate E. coli strains, produce safe substances with heptaprenyl diphosphate synthetase activity and heptaprenyl diphosphate.
This effect is achieved by preparing the above-mentioned DNA sequences from chromosomes of Bacillus stearothermophilus, which is not so far taught in scientific literature.
__________________________________________________________________________
#             SEQUENCE LISTING                                            
   - -  - - (1) GENERAL INFORMATION:                                      
   - -    (iii) NUMBER OF SEQUENCES: 14                                   
   - -  - - (2) INFORMATION FOR SEQ ID NO: 1:                             
   - -      (i) SEQUENCE CHARACTERISTICS:                                 
            (A) LENGTH:  663 bas - #e pairs                               
            (B) TYPE:  nucleic a - #cid                                   
            (C) STRANDEDNESS: double                                      
            (D) TOPOLOGY:  linear                                         
   - -     (ii) MOLECULE TYPE:  Genomic DNA                               
   - -     (vi) ORIGINAL SOURCE:                                          
            (A) ORGANISM:  Bacillus - # stearothermophilus                
   - -     (xi) SEQUENCE DESCRIPTION:  SEQ ID NO: - #1:                   
   - - ATG CTC GAT GGC GCT TCA ACG GCG CCG AGT GA - #G GCG GAG CCG TGC    
ATC       48                                                              
  Met Leu Asp Gly Ala Ser Thr Ala Pro Ser Gl - #u Ala Glu Arg Cys Ile     
                  5 - #                 10 - #                 15         
  - - ATC GCC ATG ATG CTC ATG CAG ATC GCC CTT GA - #T ACC CAC GAT GAG GTG 
      96                                                                  
 Ile Ala Met Met Leu Met Gln Ile Ala Leu As - #p Thr His Asp Glu Val      
              20     - #             25     - #             30            
  - - ACA GAT GAC GGC GGC GAC TTG CGG GCG CGG CA - #G CTT GTC GTC CTG GCC 
     144                                                                  
 Thr Asp Asp Gly Gly Asp Leu Arg Ala Arg Gl - #n Leu Val Val Leu Ala      
          35         - #         40         - #         45                
  - - GGC GAC TTG TAC AGC GGG CTG TAC TAT GAG TT - #G TTG GCG CGT TCG GGC 
     192                                                                  
 Gly Asp Leu Tyr Ser Gly Leu Tyr Tyr Glu Le - #u Leu Ala Arg Ser Gly      
      50             - #     55             - #     60                    
  - - GAA ACG GCG CTC ATC CGC TCG TTC GCC GAG GC - #G GTC CGC GAT ATT AAC 
     240                                                                  
 Glu Thr Ala Leu Ile Arg Ser Phe Ala Glu Al - #a Val Arg Asp Ile Asn      
 65                  - #70                  - #75                  - #80  
  - - GAG CAA AAA GTG CGG CTT TAC GAA AAA AAA GT - #A GAG CGG ATC GAG TCG 
     288                                                                  
 Glu Gln Lys Val Arg Leu Tyr Glu Lys Lys Va - #l Glu Arg Ile Glu Ser      
                  85 - #                 90 - #                 95        
  - - TTG TTT GCG GCG GTC GGC ACG ATC GAA TCG GC - #G TTG CTT GTC AAG CTC 
     336                                                                  
 Leu Phe Ala Ala Val Gly Thr Ile Glu Ser Al - #a Leu Leu Val Lys Leu      
             100      - #           105      - #           110            
  - - GCC GAC CGC ATG GCG GCG CCG CAG TGG GGG CA - #G TTT GCC TAT TCG TAT 
     384                                                                  
 Ala Asp Arg Met Ala Ala Pro Gln Trp Gly Gl - #n Phe Ala Tyr Ser Tyr      
         115          - #       120          - #       125                
  - - TTG CTG ATG CGG CGC CTG CTG CTC GAG CAG GA - #A GCG TTC ATC CGC ACG 
     432                                                                  
 Leu Leu Met Arg Arg Leu Leu Leu Glu Gln Gl - #u Ala Phe Ile Arg Thr      
     130              - #   135              - #   140                    
  - - GGA GCT TCG GTG CTC TTT GAG CAA ATG GCG CA - #A ATC GCG TTC CCG CGC 
     480                                                                  
 Gly Ala Ser Val Leu Phe Glu Gln Met Ala Gl - #n Ile Ala Phe Pro Arg      
 145                 1 - #50                 1 - #55                 1 -  
#60                                                                       
   - - GCG GAA ACG TTG ACG AAA GAG CAA AAG CGG CA - #T TTG CTC CGC TTT    
TGC      528                                                              
  Ala Glu Thr Leu Thr Lys Glu Gln Lys Arg Hi - #s Leu Leu Arg Phe Cys     
                 165  - #               170  - #               175        
  - - CGC CGC TAT ATC GAC GGC TGC CGG GAG GCG CT - #G TTT GCG GCG AAA CTG 
     576                                                                  
 Arg Arg Tyr Ile Asp Gly Cys Arg Glu Ala Le - #u Phe Ala Ala Lys Leu      
             180      - #           185      - #           190            
  - - CCG GTC AAC GGC CTG CTG CAG CTC CGC GTG GC - #C GTG CTT TCC GGC GGG 
     624                                                                  
 Pro Val Asn Gly Leu Leu Gln Leu Arg Val Al - #a Val Leu Ser Gly Gly      
         195          - #       200          - #       205                
  - - TTT CAA GCC ATC GCC AAA AAG ACG GTG GAA GA - #A GGG TAG             
 - #    663                                                               
 Phe Gln Ala Ile Ala Lys Lys Thr Val Glu Gl - #u Gly                      
     210              - #   215              - #   220                    
  - -  - - (2) INFORMATION FOR SEQ ID NO:2:                               
  - -      (i) SEQUENCE CHARACTERISTICS:                                  
           (A) LENGTH:  705 bas - #e pairs                                
           (B) TYPE:  nucleic a - #cid                                    
           (C) STRANDEDNESS: double                                       
           (D) TOPOLOGY:  linear                                          
  - -     (ii) MOLECULE TYPE:  Genomic DNA                                
  - -     (vi) ORIGINAL SOURCE:                                           
           (A) ORGANISM:  Bacillus - # stearothermophilus                 
  - -     (xi) SEQUENCE DESCRIPTION:  SEQ ID NO: - #2:                    
  - - ATG CGT CAA TCG AAA GAA GAG CGA GTC CAT CG - #C GTA TTT GAA AAC ATT 
      48                                                                  
 Met Arg Gln Ser Lys Glu Glu Arg Val His Ar - #g Val Phe Glu Asn Ile      
                  5 - #                 10 - #                 15         
  - - TCT GCG CAT TAT GAC CGG ATG AAC TCC GTC AT - #C AGC TTC CGC CGC CAC 
      96                                                                  
 Ser Ala His Tyr Asp Arg Met Asn Ser Val Il - #e Ser Phe Arg Arg His      
              20     - #             25     - #             30            
  - - TTG AAG TGG CGC AAA GAC GTG ATG CGG CGG AT - #G AAT GTG CAA AAA GGC 
     144                                                                  
 Leu Lys Trp Arg Lys Asp Val Met Arg Arg Me - #t Asn Val Gln Lys Gly      
          35         - #         40         - #         45                
  - - AAA AAA GCG CTC GAT GTG TGC TGT GGG ACG GC - #T GAC TGG ACG ATC GCC 
     192                                                                  
 Lys Lys Ala Leu Asp Val Cys Cys Gly Thr Al - #a Asp Trp Thr Ile Ala      
      50             - #     55             - #     60                    
  - - TTG GCG GAG GCG GTC GGT CCG GAA GGG AAA GT - #G TAC GGC CTT GAT TTC 
     240                                                                  
 Leu Ala Glu Ala Val Gly Pro Glu Gly Lys Va - #l Tyr Gly Leu Asp Phe      
 65                  - #70                  - #75                  - #80  
  - - AGC GAA AAC ATG CTG AAA GTC GGC GAA CAG AA - #G GTA AAA GCG CGC GGG 
     288                                                                  
 Ser Glu Asn Met Leu Lys Val Gly Glu Gln Ly - #s Val Lys Ala Arg Gly      
                  85 - #                 90 - #                 95        
  - - TTG CAT AAT GTG AAG CTC ATT CAC GGC AAT GC - #G ATG CAG CTG CCG TTT 
     336                                                                  
 Leu His Asn Val Lys Leu Ile His Gly Asn Al - #a Met Gln Leu Pro Phe      
             100      - #           105      - #           110            
  - - CCT GAC AAT TCG TTC GAT TAT GTG ACG ATC GG - #C TTC GGT TTG CGC AAC 
     384                                                                  
 Pro Asp Asn Ser Phe Asp Tyr Val Thr Ile Gl - #y Phe Gly Leu Arg Asn      
         115          - #       120          - #       125                
  - - GTC CCT GAC TAT ATG ACC GTG CTT AAG GAA AT - #G CAC CGG GTG ACG AAG 
     432                                                                  
 Val Pro Asp Tyr Met Thr Val Leu Lys Glu Me - #t His Arg Val Thr Lys      
     130              - #   135              - #   140                    
  - - CCG GGC GGC ATA ACC GTC TGC CTG GAA ACG TC - #G CAG CCG ACG CTG TTC 
     480                                                                  
 Pro Gly Gly Ile Thr Val Cys Leu Glu Thr Se - #r Gln Pro Thr Leu Phe      
 145                 1 - #50                 1 - #55                 1 -  
#60                                                                       
   - - GGG TTT CGC CAG CTT TAC TAT TTT TAC TTC CG - #G TTT ATT ATG CCG    
CTG      528                                                              
  Gly Phe Arg Gln Leu Tyr Tyr Phe Tyr Phe Ar - #g Phe Ile Met Pro Leu     
                 165  - #               170  - #               175        
  - - TTT GGC AAG CTG CTG GCG AAA AGC TAT GAG GA - #G TAC TCG TGG CTG CAG 
     576                                                                  
 Phe Gly Lys Leu Leu Ala Lys Ser Tyr Glu Gl - #u Tyr Ser Trp Leu Gln      
             180      - #           185      - #           190            
  - - GAA TCG GCG CGC GAG TTT CCG GGG CGG GAC GA - #G CTG GCC GAG ATC TTC 
     624                                                                  
 Glu Ser Ala Arg Glu Phe Pro Gly Arg Asp Gl - #u Leu Ala Glu Met Phe      
         195          - #       200          - #       205                
  - - CGC GCC GCC GGT TTT GTC GAT GTC GAG GTC AA - #A CCG TAC ACG TTT GGC 
     672                                                                  
 Arg Ala Ala Gly Phe Val Asp Val Glu Val Ly - #s Pro Tyr Thr Phe Gly      
     210              - #   215              - #   220                    
  - - GTG GCG GCG ATG CAC TTG GGC TAT AAA CGG TG - #A                  -  
#        705                                                              
  Val Ala Ala Met His Leu Gly Tyr Lys Arg                                 
  225                 2 - #30                                             
   - -  - - (2) INFORMATION FOR SEQ ID NO:3:                              
   - -      (i) SEQUENCE CHARACTERISTICS:                                 
            (A) LENGTH:  972 bas - #e pairs                               
            (B) TYPE:  nucleic a - #cid                                   
            (C) STRANDEDNESS: double                                      
            (D) TOPOLOGY:  linear                                         
   - -     (ii) MOLECULE TYPE:  Genomic DNA                               
   - -     (vi) ORIGINAL SOURCE:                                          
            (A) ORGANISM:  Bacillus - # stearothermophilus                
   - -     (xi) SEQUENCE DESCRIPTION:  SEQ ID NO: - #3:                   
   - - GTG AAC AAC ATG AAG TTA AAG GCG ATG TAT TC - #G TTT TTA AGC GAT    
GAT       48                                                              
  Val Asn Asn Met Lys Leu Lys Ala Met Tyr Se - #r Phe Leu Ser Asp Asp     
                  5 - #                 10 - #                 15         
  - - TTA GCG GCG GTC GAA GAG GAG CTT GAG CGG GC - #G GTT CAG TCG GAA TAC 
      96                                                                  
 Leu Ala Ala Val Glu Glu Glu Leu Glu Arg Al - #a Val Gln Ser Glu Tyr      
              20     - #             25     - #             30            
  - - GGG CCG CTT GGG GAA GCG GCG CTC CAT CTG TT - #G CAG GCG GGC GGA AAG 
     144                                                                  
 Gly Pro Leu Gly Glu Ala Ala Leu His Leu Le - #u Gln Ala Gly Gly Lys      
          35         - #         40         - #         45                
  - - CGG ATC CGT CCC GTT TTT GTC TTG CTT GCC GC - #C CGC TTC GGC CAA TAT 
     192                                                                  
 Arg Ile Arg Pro Val Phe Val Leu Leu Ala Al - #a Arg Phe Gly Gln Tyr      
      50             - #     55             - #     60                    
  - - GAC CTT GAG CGG ATG AAG CAT GTT GCC GTT GC - #G CTC GAG CTC ATT CAT 
     240                                                                  
 Asp Leu Glu Arg Met Lys His Val Ala Val Al - #a Leu Glu Leu Ile His      
 65                  - #70                  - #75                  - #80  
  - - ATG GCT TCG CTC GTC CAC GAC GAT GTG ATC GA - #C GAC GCC GAT TTG CGC 
     288                                                                  
 Met Ala Ser Leu Val His Asp Asp Val Ile As - #p Asp Ala Asp Leu Arg      
                  85 - #                 90 - #                 95        
  - - CGC GGC CGG CCG ACG ATC AAG GCG AAA TGG AG - #C AAC GCC TTC GCC ATG 
     336                                                                  
 Arg Gly Arg Pro Thr Ile Lys Ala Lys Trp Se - #r Asn Arg Phe Ala Met      
             100      - #           105      - #           110            
  - - TAC ACA GGG GAT TAT TTG TTT GCC CGC TCG CT - #C GAA CGG ATG GCG GAG 
     384                                                                  
 Tyr Thr Gly Asp Tyr Leu Phe Ala Arg Ser Le - #u Glu Arg Met Ala Glu      
         115          - #       120          - #       125                
  - - CTC GGC AAC CCG CGC GCC CAT CAA GTG TTG GC - #G AAA ACG ATC GTG GAA 
     432                                                                  
 Leu Gly Asn Pro Arg Ala His Gln Val Leu Al - #a Lys Thr Ile Val Glu      
     130              - #   135              - #   140                    
  - - GTG TGC CGC GGG GAA ATT GAG CAA ATT AAA GA - #C AAG TAC CGG TTT GAT 
     480                                                                  
 Val Cys Arg Gly Glu Ile Glu Gln Ile Lys As - #p Lys Tyr Arg Phe Asp      
 145                 1 - #50                 1 - #55                 1 -  
#60                                                                       
   - - CAG CCG CTG CGC ACG TAT TTG CGG CGC ATC CG - #T CGG AAA ACG GCG    
CTG      528                                                              
  Gln Pro Leu Arg Thr Tyr Leu Arg Arg Ile Ar - #g Arg Lys Thr Ala Leu     
                 165  - #               170  - #               175        
  - - CTC ATC GCC GCG AGC TGC CAG CTT GGC GCC CT - #C GCT GCC GGC GCG CCG 
     576                                                                  
 Leu Ile Ala Ala Ser Cys Gln Leu Gly Ala Le - #u Ala Ala Gly Ala Pro      
             180      - #           185      - #           190            
  - - GAG CCG ATT GTG AAG CGG CTG TAC TGG TTC GG - #C CAT TAT GTC GGC ATG 
     624                                                                  
 Glu Pro Ile Val Lys Arg Leu Tyr Trp Phe Gl - #y His Tyr Val Gly Met      
         195          - #       200          - #       205                
  - - TCG TTT CAA ATT ACC GAC GAC ATT CTC GAT TT - #C ACT GGG ACG GAG GAA 
     672                                                                  
 Ser Phe Gln Ile Thr Asp Asp Ile Leu Asp Ph - #e Thr Gly Thr GLu Glu      
     210              - #   215              - #   220                    
  - - CAG CTC GGC AAA CCG GCC GGA AGC GAC TTG CT - #A CAA GGA AAC GTC ACC 
     720                                                                  
 Gln Leu Gly Lys Pro Ala Gly Ser Asp Leu Le - #u Gln Gly Asn Val Thr      
 225                 2 - #30                 2 - #35                 2 -  
#40                                                                       
   - - CTT CCT GTG CTG TAT GCC TTG AGC GAT GAG CG - #G GTG AAG GCG GCC    
ATT      768                                                              
  Leu Pro Val Leu Tyr Ala Leu Ser Asp Glu Ar - #g Val Lys Ala Ala Ile     
                 245  - #               250  - #               255        
  - - GCA GCT GTC GGT CCG GAA ACG GAC GTT GCG GA - #A ATG GCG GCG GTC ATT 
     816                                                                  
 Ala Ala Val Gly Pro Glu Thr Asp Val Ala Gl - #u Met Ala Ala Val Ile      
             260      - #           265      - #           270            
  - - TCC GCC ATT AAG CGG ACG GAC GCC ATT GAG CG - #G TCG TAT GCG TTA AGC 
     864                                                                  
 Ser Ala Ile Lys Arg Thr Asp Ala Ile Glu Ar - #g Ser Tyr Ala Leu Ser      
         275          - #       280          - #       285                
  - - GAC CGT TAC CTT GAC AAG GCG CTT CAC CTT CT - #T GAC GGA CTG CCG ATG 
     912                                                                  
 Asp Arg Tyr Leu Asp Lys Ala Leu His Leu Le - #u Asp Gly Leu Pro Met      
     290              - #   295              - #   300                    
  - - AAT GAG GCG CGC GGC CTG TTG CGC GAC CTC GC - #C CTT TAC ATC GGG AAA 
     960                                                                  
 Asn Glu Ala Arg Gly Leu Leu Arg Asp Leu Al - #a Leu Tyr Ile Gly Lys      
 305                 3 - #10                 3 - #15                 3 -  
#20                                                                       
   - - AGG GAT TAT TAA            - #                  - #                
  - #      972                                                            
 Arg Asp Tyr                                                              
  - -  - - (2) INFORMATION FOR SEQ ID NO:4:                               
  - -      (i) SEQUENCE CHARACTERISTICS:                                  
           (A) LENGTH:  30                                                
           (B) TYPE:  nucleic a - #cid                                    
           (C) STRANDEDNESS: single                                       
           (D) TOPOLOGY:  linear                                          
  - -     (ii) MOLECULE TYPE:  Synthetic DNA                              
  - -     (xi) SEQUENCE DESCRIPTION:  SEQ ID NO: - #4:                    
  - - CTNATHCAYG AYGAYYTNCC NTCNATGGAC         - #                  - #   
      30                                                                  
  - -  - - (2) INFORMATION FOR SEQ ID NO:5:                               
  - -      (i) SEQUENCE CHARACTERISTICS:                                  
           (A) LENGTH:  24                                                
           (B) TYPE:  nucleic a - #cid                                    
           (C) STRANDEDNESS: single                                       
           (D) TOPOLOGY:  linear                                          
  - -     (ii) MOLECULE TYPE:  Synthetic DNA                              
  - -     (xi) SEQUENCE DESCRIPTION:  SEQ ID NO: - #5:                    
  - - GAYAAYGAYG AYYTNMGNMG NGGC          - #                  - #        
        24                                                                
  - -  - - (2) INFORMATION FOR SEQ ID NO:6:                               
  - -      (i) SEQUENCE CHARACTERISTICS:                                  
           (A) LENGTH:  27                                                
           (B) TYPE:  nucleic a - #cid                                    
           (C) STRANDEDNESS: single                                       
           (D) TOPOLOGY:  linear                                          
  - -     (ii) MOLECULE TYPE:  Synthetic DNA                              
  - -     (xi) SEQUENCE DESCRIPTION:  SEQ ID NO: - #6:                    
  - - ATCRTCNCKD ATYTGRAANG CNARNCC          - #                  - #     
        27                                                                
  - -  - - (2) INFORMATION FOR SEQ ID NO:7:                               
  - -      (i) SEQUENCE CHARACTERISTICS:                                  
           (A) LENGTH:  27                                                
           (B) TYPE:  nucleic a - #cid                                    
           (C) STRANDEDNESS: single                                       
           (D) TOPOLOGY:  linear                                          
  - -     (ii) MOLECULE TYPE:  Synthetic DNA                              
  - -     (xi) SEQUENCE DESCRIPTION:  SEQ ID NO: - #7:                    
  - - ATCNARDATR TCRTCNCKDA TYTGRAA          - #                  - #     
        27                                                                
  - -  - - (2) INFORMATION FOR SEQ ID NO:8:                               
  - -      (i) SEQUENCE CHARACTERISTICS:                                  
           (A) LENGTH:  21                                                
           (B) TYPE:  nucleic a - #cid                                    
           (C) STRANDEDNESS: single                                       
           (D) TOPOLOGY:  linear                                          
  - -     (ii) MOLECULE TYPE:  Synthetic DNA                              
  - -     (xi) SEQUENCE DESCRIPTION:  SEQ ID NO: - #8:                    
  - - GTCRCTNCCN ACNGGYTTNC C           - #                  - #          
        - #21                                                             
  - -  - - (2) INFORMATION FOR SEQ ID NO:9:                               
  - -      (i) SEQUENCE CHARACTERISTICS:                                  
           (A) LENGTH:  20                                                
           (B) TYPE:  nucleic a - #cid                                    
           (C) STRANDEDNESS: single                                       
           (D) TOPOLOGY:  linear                                          
  - -     (ii) MOLECULE TYPE:  Synthetic DNA                              
  - -     (xi) SEQUENCE DESCRIPTION:  SEQ ID NO: - #9:                    
  - - YTNGARGCNG GNGGNAARMG            - #                  - #           
       - # 20                                                             
  - -  - - (2) INFORMATION FOR SEQ ID NO:10:                              
  - -      (i) SEQUENCE CHARACTERISTICS:                                  
           (A) LENGTH:  20                                                
           (B) TYPE:  nucleic a - #cid                                    
           (C) STRANDEDNESS: single                                       
           (D) TOPOLOGY:  linear                                          
  - -     (ii) MOLECULE TYPE:  Synthetic DNA                              
  - -     (xi) SEQUENCE DESCRIPTION:  SEQ ID NO: - #10:                   
  - - TAYWSNYTNA THCAYGAYGA            - #                  - #           
       - # 20                                                             
  - -  - - (2) INFORMATION FOR SEQ ID NO:11:                              
  - -      (i) SEQUENCE CHARACTERISTICS:                                  
           (A) LENGTH:  21                                                
           (B) TYPE:  nucleic a - #cid                                    
           (C) STRANDEDNESS: single                                       
           (D) TOPOLOGY:  linear                                          
  - -     (ii) MOLECULE TYPE:  Synthetic DNA                              
  - -     (xi) SEQUENCE DESCRIPTION:  SEQ ID NO: - #11:                   
  - - YTCCATRTCN GCNGCYTGNC C           - #                  - #          
        - #21                                                             
  - - (2) INFORMATION FOR SEQ ID NO:12:                                   
  - -      (i) SEQUENCE CHARACTERISTICS:                                  
           (A) LENGTH:  26                                                
           (B) TYPE:  nucleic a - #cid                                    
           (C) STRANDEDNESS: single                                       
           (D) TOPOLOGY:  linear                                          
  - -     (ii) MOLECULE TYPE:  Synthetic DNA                              
  - -     (xi) SEQUENCE DESCRIPTION:  SEQ ID NO: - #12:                   
  - - YTNGARTAYA THCAYMGNCA YAARAC          - #                  - #      
        26                                                                
  - -  - - (2) INFORMATION FOR SEQ ID NO:13:                              
  - -      (i) SEQUENCE CHARACTERISTICS:                                  
           (A) LENGTH:  18                                                
           (B) TYPE:  nucleic a - #cid                                    
           (C) STRANDEDNESS: single                                       
           (D) TOPOLOGY:  linear                                          
  - -     (ii) MOLECULE TYPE:  Synthetic DNA                              
  - -     (xi) SEQUENCE DESCRIPTION:  SEQ ID NO: - #13:                   
  - - DATRTCNARD ATRTCRTC             - #                  - #            
      - #  18                                                             
  - -  - - (2) INFORMATION FOR SEQ ID NO:14:                              
  - -      (i) SEQUENCE CHARACTERISTICS:                                  
           (A) LENGTH:  20                                                
           (B) TYPE:  nucleic a - #cid                                    
           (C) STRANDEDNESS: single                                       
           (D) TOPOLOGY:  linear                                          
  - -     (ii) MOLECULE TYPE:  Synthetic DNA                              
  - -     (xi) SEQUENCE DESCRIPTION:  SEQ ID NO: - #14:                   
  - - GATCACATCG TCGTGGACGA            - #                  - #           
       - # 20                                                             
__________________________________________________________________________

Claims (6)

We claim:
1. A protein of Bacillus stearothermophilus origin with heptaprenyl diphosphate synthetase activity, which comprises a peptide encoded by nucleotides 1-660 of SEQ ID NO. 1, a peptide encoded by nucleotides 1-702 of SEQ ID NO. 2, and a peptide encoded by nucleotides 1-969 of SEQ ID NO. 3.
2. A peptide of Bacillus stearothermophilus origin encoded by nucleotides 1-660 of SEQ ID NO. 1.
3. A peptide of Bacillus stearothermophilus origin encoded by nucleotides 1-969 of SEQ ID NO. 3.
4. A protein of Bacillus stearothermophilus origin with heptaprenyl diphosphate synthetase activity, which comprises a peptide encoded by nucleotides 1-66 of SEQ ID NO. 1, and a peptide encoded by nucleotides 1-969 of SEQ ID NO. 3.
5. A protein of Bacillus stearothermophilus origin, which comprises a peptide encoded by nucleotides 1-660 of SEQ ID NO. 1, and a peptide encoded by nucleotides 1-7 of SEQ ID NO. 2.
6. A protein of Bacillus stearothermophilus origin, which comprises a peptide encoded by nucleotides 1-702 of SEQ ID NO. 2, and a peptide encoded by nucleotides 1-9 of SEQ ID NO. 3.
US09/035,754 1994-07-29 1998-03-06 Heptaprenyl diphosphate-synthetase Expired - Lifetime US6020177A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/035,754 US6020177A (en) 1994-07-29 1998-03-06 Heptaprenyl diphosphate-synthetase

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP6-179336 1994-07-29
JP06179336A JP3087575B2 (en) 1994-07-29 1994-07-29 Heptaprenyl diphosphate synthase and DNA encoding the same
US08/506,404 US5773265A (en) 1994-07-29 1995-07-24 DNA encoding heptaprenyl diphosphate synthetase
US09/035,754 US6020177A (en) 1994-07-29 1998-03-06 Heptaprenyl diphosphate-synthetase

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US08/506,404 Division US5773265A (en) 1994-07-29 1995-07-24 DNA encoding heptaprenyl diphosphate synthetase

Publications (1)

Publication Number Publication Date
US6020177A true US6020177A (en) 2000-02-01

Family

ID=16064063

Family Applications (2)

Application Number Title Priority Date Filing Date
US08/506,404 Expired - Lifetime US5773265A (en) 1994-07-29 1995-07-24 DNA encoding heptaprenyl diphosphate synthetase
US09/035,754 Expired - Lifetime US6020177A (en) 1994-07-29 1998-03-06 Heptaprenyl diphosphate-synthetase

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US08/506,404 Expired - Lifetime US5773265A (en) 1994-07-29 1995-07-24 DNA encoding heptaprenyl diphosphate synthetase

Country Status (4)

Country Link
US (2) US5773265A (en)
EP (1) EP0699761B1 (en)
JP (1) JP3087575B2 (en)
DE (1) DE69501069T2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7851199B2 (en) 2005-03-18 2010-12-14 Microbia, Inc. Production of carotenoids in oleaginous yeast and fungi
US8618355B2 (en) 2008-03-17 2013-12-31 National Research Council Of Canada Aromatic prenyltransferase from hop
US8691555B2 (en) 2006-09-28 2014-04-08 Dsm Ip Assests B.V. Production of carotenoids in oleaginous yeast and fungi

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3120684B2 (en) * 1995-02-14 2000-12-25 トヨタ自動車株式会社 Mutant farnesyl diphosphate synthase that synthesizes geranylgeranyl diphosphate and DNA encoding the same
US6174715B1 (en) * 1996-06-14 2001-01-16 Toyota Jidosha Kabushiki Kaisha Prenyl diphosphate synthetase genes
JP3379344B2 (en) 1996-07-24 2003-02-24 トヨタ自動車株式会社 Farnesyl diphosphate synthase
US6984223B2 (en) 2001-11-13 2006-01-10 Becton, Dickinson And Company Needle safety device
CN110028549B (en) * 2016-07-07 2022-08-05 华东理工大学 Antihypertensive peptide and antihypertensive protein and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0674000A2 (en) * 1994-03-24 1995-09-27 Toyota Jidosha Kabushiki Kaisha Geranylgeranyl diphosphate synthase and DNA coding therefor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0674000A2 (en) * 1994-03-24 1995-09-27 Toyota Jidosha Kabushiki Kaisha Geranylgeranyl diphosphate synthase and DNA coding therefor

Non-Patent Citations (22)

* Cited by examiner, † Cited by third party
Title
FEBS Letters , 161:2 pp. 257 260, Sep. 19, 1983, Amsterdam, NL, Essential Protein Factors for Polyprenyl Pyrophosphase Synthetases . . . , H. Fuji, et al. *
FEBS Letters, 161:2 pp. 257-260, Sep. 19, 1983, Amsterdam, NL, Essential Protein Factors for Polyprenyl Pyrophosphase Synthetases . . . , H. Fuji, et al.
J. Biochem., 113:3, pp. 355 363, Mar. 1993, Tokyo, JP: Thermostable Farnesyl Diphosphate Synthase . . . Overproduction and Purification, T. Koyama, et al. *
J. Biochem., 113:3, pp. 355-363, Mar. 1993, Tokyo, JP: Thermostable Farnesyl Diphosphate Synthase . . . Overproduction and Purification, T. Koyama, et al.
J. Biochem., 270:31, pp. 18396 18400, Aug. 1995, Maryland, US: Molecular Cloning and Nucleotide Sequences . . . Heptaprenyl Diphosphate Synthesis, A. Koike Takeshita, et al. *
J. Biochem., 270:31, pp. 18396-18400, Aug. 1995, Maryland, US: Molecular Cloning and Nucleotide Sequences . . . Heptaprenyl Diphosphate Synthesis, A. Koike-Takeshita, et al.
J. Biol. Chem. , 269:20, May 20 1994, Ohnuma, et al., pp. 14792 14797. *
J. Biol. Chem. 255, pp. 4539 3543 (1980). *
J. Biol. Chem. 255, pp. 4539-3543 (1980).
J. Biol. Chem. 265, pp. 4607 4614 (1990). *
J. Biol. Chem. 265, pp. 4607-4614 (1990).
J. Biol. Chem., 269:20, May 20 1994, Ohnuma, et al., pp. 14792-14797.
Koyama et al. (1994) Tennen Yuki Kagobutsu Toronkai Koen Yoshishu, 36th, 167 174 (abstract). *
Koyama et al. (1994) Tennen Yuki Kagobutsu Toronkai Koen Yoshishu, 36th, 167-174 (abstract).
Koyama et al., paper published by Organizing Committe of the 36th Symposium on the Chemistry of Natural products, Sep. 20, 1994, pp. 167 174. *
Koyama et al., paper published by Organizing Committe of the 36th Symposium on the Chemistry of Natural products, Sep. 20, 1994, pp. 167-174.
Proc. Natl. Acad. Sci. USA, pp. 6761 6764 (1992). *
Proc. Natl. Acad. Sci. USA, pp. 6761-6764 (1992).
Stedman s Medical Dictionary, 26th ed., 1995. *
Stedman's Medical Dictionary, 26th ed., 1995.
Summary of 17th Meeting of Japanese Molecular Biology Society (1994). *
Summary of 67th Meeting of Japanese Biochemical Society No. 1728 (1994). *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7851199B2 (en) 2005-03-18 2010-12-14 Microbia, Inc. Production of carotenoids in oleaginous yeast and fungi
US8288149B2 (en) 2005-03-18 2012-10-16 Dsm Ip Assets B.V. Production of carotenoids in oleaginous yeast and fungi
US9909130B2 (en) 2005-03-18 2018-03-06 Dsm Ip Assets B.V. Production of carotenoids in oleaginous yeast and fungi
US8691555B2 (en) 2006-09-28 2014-04-08 Dsm Ip Assests B.V. Production of carotenoids in oleaginous yeast and fungi
US9297031B2 (en) 2006-09-28 2016-03-29 Dsm Ip Assets B.V. Production of carotenoids in oleaginous yeast and fungi
US8618355B2 (en) 2008-03-17 2013-12-31 National Research Council Of Canada Aromatic prenyltransferase from hop

Also Published As

Publication number Publication date
JP3087575B2 (en) 2000-09-11
JPH0838168A (en) 1996-02-13
EP0699761B1 (en) 1997-11-19
EP0699761A2 (en) 1996-03-06
EP0699761A3 (en) 1996-05-08
US5773265A (en) 1998-06-30
DE69501069T2 (en) 1998-04-09
DE69501069D1 (en) 1998-01-02

Similar Documents

Publication Publication Date Title
US5928919A (en) Variant DNA polymerases
Lung et al. Molecular cloning, DNA sequence, and gene expression of the oxalyl-coenzyme A decarboxylase gene, oxc, from the bacterium Oxalobacter formigenes
US6083686A (en) Increased production of Thermus aquaticus DNA polymerase in E. coli
US6133014A (en) Maleate isomerase gene
JP3538998B2 (en) Long-chain prenyl diphosphate synthase
Okada et al. Cloning of the sdsA gene encoding solanesyl diphosphate synthase from Rhodobacter capsulatus and its functional expression in Escherichia coli and Saccharomyces cerevisiae
US6020177A (en) Heptaprenyl diphosphate-synthetase
CA2281206C (en) Geranyl diphosphate synthase genes
US6033859A (en) Thermostable DNA polymerase from a hyperthermophilic archaeon strain KOD1
JP3120684B2 (en) Mutant farnesyl diphosphate synthase that synthesizes geranylgeranyl diphosphate and DNA encoding the same
JP3376838B2 (en) Prenyl diphosphate synthase
US6040165A (en) Mutant prenyl diphosphate synthase
US5932440A (en) Mammalian ribonuclease inhibitors and use thereof
US6071733A (en) Method of making recombinant enzyme
US6107072A (en) Thermostable geranylgeranyl diphosphate synthase
US5786192A (en) Farnesyl pyrophosphate synthetase and DNA sequence encoding the same
US5948670A (en) Process for the isolation and characterization of a gene enzyme system for inactivation of the herbicide phenmedipham and transfer of the gene into plants to produce herbicide-tolerant plants
US6080553A (en) Creatine amidinohydrolase, production thereof and use thereof
US5912154A (en) Geranylgeranyl diphosphate synthase proteins, nucleic acid molecules and uses thereof
JP3148455B2 (en) E1 protein of mutant pyruvate dehydrogenase complex Gene and E1 protein of mutant pyruvate dehydrogenase complex
US6043076A (en) Gene encoding 2,3-dihydroxybenzoic acid decarboxylase
US6069241A (en) Cytochrome P450 gene
US6214590B1 (en) 2-aminothiazoline-4-carboxylate racemase and gene encoding therefor
JPH06303981A (en) Dna having genetic information on protein having formaldehyde dehydrogenase activity and production of formaldehyde dehydrogenase
JP3396740B2 (en) Gene encoding phosphoenolpyruvate carboxylase

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12